Background: Childhood attention-deficit/hyperactivity disorder (ADHD) is a risk factor for substance misuse and substance use disorder (SUD) in adolescence and (early) adulthood. ADHD and SUD also frequently co-occur in treatment-seeking adolescents, which complicates diagnosis and treatment and is associated with poor treatment outcomes. Research on the effect of treatment of childhood ADHD on the prevention of adolescent SUD is inconclusive, and studies on the diagnosis and treatment of adolescents with ADHD and SUD are scarce. Thus, the available evidence is generally not sufficient to justify robust treatment recommendations. Objective: The aim of the study was to obtain a consensus statement based on a combination of scientific data and clinical experience. Method: A modified Delphi study to reach consensus based upon the combination of scientific data and clinical experience with a multidisciplinary group of 55 experts from 17 countries. The experts were asked to rate a set of statements on the effect of treatment of childhood ADHD on adolescent SUD and on the screening, diagnosis, and treatment of adolescents with comorbid ADHD and SUD. Results: After 3 iterative rounds of rating and adapting 37 statements, consensus was reached on 36 of these statements representing 6 domains: general (n = 4), risk of developing SUD (n = 3), screening and diagnosis (n = 7), psychosocial treatment (n = 5), pharmacological treatment (n = 11), and complementary treatments (n = 7). Routine screening is recommended for ADHD in adolescent patients in substance abuse treatment and for SUD in adolescent patients with ADHD in mental healthcare settings. Long-acting stimulants are recommended as the first-line treatment of ADHD in adolescents with concurrent ADHD and SUD, and pharmacotherapy should preferably be embedded in psychosocial treatment. The only remaining no-consensus statement concerned the requirement of abstinence before starting pharmacological treatment in adolescents with ADHD and concurrent SUD. In contrast to the majority, some experts required full abstinence before starting any pharmacological treatment, some were against the use of stimulants in the treatment of these patients (independent of abstinence), while some were against the alternative use of bupropion. Conclusion: This international consensus statement can be used by clinicians and patients together in a shared decision-making process to select the best interventions and to reach optimal outcomes in adolescent patients with concurrent ADHD and SUD.

1.
van Emmerik-van Oortmerssen
K
,
van de Glind
G
,
van den Brink
W
,
Smit
F
,
Crunelle
CL
,
Swets
M
,
.
Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis
.
Drug Alcohol Depend
.
2012 Apr
;
122
(
1–2
):
11
9
.
2.
Wilens
TE
,
Morrison
NR
.
Substance-use disorders in adolescents and adults with ADHD: focus on treatment
.
Neuropsychiatry
.
2012 Aug
;
2
(
4
):
301
12
.
3.
Groenman
AP
,
Oosterlaan
J
,
Rommelse
N
,
Franke
B
,
Roeyers
H
,
Oades
RD
,
.
Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study
.
Addiction
.
2013 Aug
;
108
(
8
):
1503
11
.
4.
Groenman
AP
,
Janssen
TWP
,
Oosterlaan
J
.
Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis
.
J Am Acad Child Adolesc Psychiatry
.
2017 Jul
;
56
(
7
):
556
69
.
5.
Groenman
AP
,
Schweren
LJS
,
Weeda
W
,
Luman
M
,
Noordermeer
SDS
,
Heslenfeld
DJ
,
.
Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
.
Eur Child Adolesc Psychiatry
.
2019 Sep 1
;
28
(
9
):
1213
22
.
6.
Quinn
PD
,
Chang
Z
,
Hur
K
,
Gibbons
RD
,
Lahey
BB
,
Rickert
ME
,
.
ADHD medication and substance-related problems
.
Am J Psychiatr
.
2017 Sep 1
;
174
(
9
):
877
85
.
7.
Humphreys
KL
,
Eng
T
,
Lee
SS
.
Stimulant medication and substance use outcomes: a meta-analysis
.
JAMA Psychiatry
.
2013 Jul 1
;
70
(
7
):
740
9
.
8.
Molina
BS
,
Hinshaw
SP
,
Eugene Arnold
L
,
Swanson
JM
,
Pelham
WE
,
Hechtman
L
,
.
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication
.
J Am Acad Child Adolesc Psychiatry
.
2013 Mar 1
;
52
(
3
):
250
63
.
9.
Landelijke Stuurgroep Multidisciplinaire richtlijnontwikkeling in de GGZ
.
Multidisciplinaire Richtlijn ADHD bij Kinderen en Jeugdigen
.
Utrecht
:
Trimbos-Instituut
;
2005
.
10.
National Health and Medical Research Council
.
Draft Australian Guidelines on Attention Deficit Hyperactivity Disorder
.
(ADHD)
;
2009
. Available from: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/ch54_draft_guidelines.pdf.
11.
Scottish Intercollegiate Guidelines Network
.
Edinburgh
:
The Network; Management of attention deficit and hyperkinetic disorders in children and young people: a national clinical guideline [Internet]
;
2009 Oct
. Available from: http://www.sign.ac.uk/.
12.
Association of the scientific medical societies in Germany (AWMF) online
.
Interdisciplinary Evidence- and Consensus-Based Guideline “Attention Deficit/Hyperactivity Disorder in Children, Young People and Adults”
.
[in German]
;
2018
. https://www.awmf.org/uploads/tx_szleitlinien/028- 045l_S3_ADHS_2018-06.pdf.
13.
Canadian ADHD Resource Alliance (CADDRA)
.
Canadian ADHD practice guidelines
. 4th ed.
Toronto, ON
:
CADDRA
;
2018
.
14.
Wolraich
ML
,
Hagan
JF
,
Wolraich
M
,
Brown
L
,
Brown
RT
,
DuPaul
G
,
.
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents
.
Pediatrics
.
2019 Oct 1
;
128
(
5
):
1007
22
.
15.
National Institute for Health and Care Excellence
.
Attention defificit hyperactivity disorder: diagnosis and management
.
NG87
;
March 2018
. Available from: www.nice.org.uk/guidance/ng87.
16.
Chan
E
,
Fogler
JM
,
Hammerness
PG
.
Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review
.
JAMA
.
2016 May 10
;
315
(
18
):
1997
2008
.
17.
Sibley
MH
,
Kuriyan
AB
,
Evans
SW
,
Waxmonsky
JG
,
Smith
BH
.
Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature
.
Clin Psychol Rev
.
2014 Apr 1
;
34
(
3
):
218
32
.
18.
Knight
JR
,
Sherritt
L
,
Harris
SK
,
Gates
EC
,
Chang
G
.
Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT
.
Alcohol Clin Exp Res
.
2003 Jan
;
27
(
1
):
67
73
.
19.
Babor
TF
,
Robaina
K
.
The alcohol use disorders identification test (AUDIT): a review of graded severity algorithms and national adaptations
.
Int J Alcohol Drug Res
.
2016
;
5
(
2
):
17
24
.
20.
DuPaul
GJ
,
Reid
R
,
Anastopoulos
AD
,
Lambert
MC
,
Watkins
MW
,
Power
TJ
.
Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data
.
Psychol Assess
.
2016 Feb
;
28
(
2
):
214
25
.
21.
Ustun
B
,
Adler
LA
,
Rudin
C
,
Faraone
SV
,
Spencer
TJ
,
Berglund
P
,
.
The world health organization adult attention-deficit/hyperactivity disorder self-report screening scale for DSM-5
.
JAMA Psychiatry
.
2017 May 1
;
74
(
5
):
520
6
.
22.
Evans
SW
,
Serpell
ZN
,
Schultz
BK
,
Pastor
DA
.
Cumulative benefits of secondary school-based treatment of students with attention deficit hyperactivity disorder
.
Sch Psychol Rev
.
2007
;
36
(
2
):
256
73
.
23.
Evans
SW
,
Langberg
JM
,
Schultz
BK
,
Vaughn
A
,
Altaye
M
,
Marshall
SA
,
.
Evaluation of a school-based treatment program for young adolescents with ADHD
.
J Consult Clin Psychol
.
2016
;
84
(
1
):
15
30
.
24.
Langberg
JM
,
Epstein
JN
,
Becker
SP
,
Girio-Herrera
E
,
Vaughn
AJ
.
Evaluation of the homework, organization, and planning skills (HOPS) intervention for middle school students with ADHD as implemented by school mental health providers
.
School Psych Rev
.
2012 Sep 1
;
41
(
3
):
342
64
.
25.
Schramm
SA
,
Hennig
T
,
Linderkamp
F
.
Training problem solving and organizational skills in adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial
.
J Cognit Educ Psychol
.
2016 Jan 1
;
15
(
3
):
391
411
.
26.
Steeger
CM
,
Gondoli
DM
,
Gibson
BS
,
Morrissey
RA
.
Combined cognitive and parent training interventions for adolescents with ADHD and their mothers: a randomized controlled trial
.
Child Neuropsychol
.
2016 May 18
;
22
(
4
):
394
419
.
27.
Barkley
RA
,
Edwards
G
,
Laneri
M
,
Fletcher
K
,
Metevia
L
.
The efficacy of problem-solving communication training alone, behavior management training alone, and their combination for parent-adolescent conflict in teenagers with ADHD and ODD
.
J Consult Clin Psychol
.
2001 Dec
;
69
(
6
):
926
41
.
28.
Boyer
BE
,
Geurts
HM
,
Prins
PJ
,
Van der Oord
S
.
Two novel CBTs for adolescents with ADHD: the value of planning skills
.
Eur Child Adolesc Psychiatr
.
2015 Sep 1
;
24
(
9
):
1075
90
.
29.
Sibley
MH
,
Graziano
PA
,
Kuriyan
AB
,
Coxe
S
,
Pelham
WE
,
Rodriguez
L
,
.
Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD
.
J Consult Clin Psychol
.
2016 Aug
;
84
(
8
):
699
712
.
30.
Sibley
MH
,
Rodriguez
L
,
Coxe
S
,
Page
T
,
Espinal
K
.
Parent-teen group versus dyadic treatment for adolescent adhd: what works for whom
.
J Clin Child Adolesc Psychol
.
2019 Apr 18
;
16
:
1
17
.
31.
Sprich
SE
,
Safren
SA
,
Finkelstein
D
,
Remmert
JE
,
Hammerness
P
.
A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents
.
J Child Psychol Psychiatry
.
2016 Nov
;
57
(
11
):
1218
26
.
32.
Vidal
R
,
Castells
J
,
Richarte
V
,
Palomar
G
,
García
M
,
Nicolau
R
,
.
Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial
.
J Am Acad Child Adolesc Psychiatry
.
2015 Apr 1
;
54
(
4
):
275
82
.
33.
van Emmerik-van Oortmerssen
K
,
Vedel
E
,
Kramer
FJ
,
Blankers
M
,
Dekker
JJM
,
van den Brink
W
,
.
Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: results of a randomized clinical trial
.
Drug Alcohol Depend
.
2019 Apr 1
;
197
:
28
36
.
34.
Gray
SA
,
Chaban
P
,
Martinussen
R
,
Goldberg
R
,
Gotlieb
H
,
Kronitz
R
,
.
Effects of a computerized working memory training program on working memory, attention, and academics in adolescents with severe LD and comorbid ADHD: a randomized controlled trial
.
J Child Psychol Psychiatry
.
2012 Dec
;
53
(
12
):
1277
84
.
35.
Bink
M
,
Bongers
IL
,
Popma
A
,
Janssen
TW
,
van Nieuwenhuizen
C
.
1-year follow-up of neurofeedback treatment in adolescents with attention-deficit hyperactivity disorder: randomised controlled trial
.
BJPsych Open
.
2016 Mar
;
2
(
2
):
107
15
.
36.
Matsudaira
T
,
Gow
RV
,
Kelly
J
,
Murphy
C
,
Potts
L
,
Sumich
A
,
.
Biochemical and psychological effects of omega-3/6 supplements in male adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, clinical trial
.
J Child Adolesc Psychopharmacol
.
2015 Dec
;
25
(
10
):
775
82
.
37.
Ahmed
GM
,
Mohamed
S
.
Effect of regular aerobic exercises on behavioral, cognitive, and psychological response in patients with attention deficit-hyperactivity disorder
.
Life Sci J
.
2011
;
8
(
2
):
366
71
.
38.
Cunill
R
,
Castells
X
,
Tobias
A
,
Capellà
D
.
Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
.
J Psychopharmacol
.
2015 Jan
;
29
(
1
):
15
23
.
39.
Carpentier
PJ
,
Levin
FR
.
Pharmacological treatment of ADHD in addicted patients: what does the literature tell us
.
Harv Rev Psychiatr
.
2017 Mar/Apr
;
25
(
2
):
50
64
.
40.
Riggs
PD
,
Winhusen
T
,
Davies
RD
,
Leimberger
JD
,
Mikulich-Gilbertson
S
,
Klein
C
,
.
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders
.
J Am Acad Child Adolesc Psychiatry
.
2011 Sep 1
;
50
(
9
):
903
14
.
41.
Szobot
CM
,
Rohde
LA
,
Katz
B
,
Ruaro
P
,
Schaefer
T
,
Walcher
M
,
.
A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder
.
Braz J Med Biol Res
.
2008 Mar
;
41
(
3
):
250
7
.
42.
Riggs
PD
,
Hall
SK
,
Mikulich-Gilbertson
SK
,
Lohman
M
,
Kayser
A
.
A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents
.
J Am Acad Child Adolesc Psychiatry
.
2004 Apr
;
43
(
4
):
420
9
.
43.
Thurstone
C
,
Riggs
PD
,
Salomonsen-Sautel
S
,
Mikulich-Gilbertson
SK
.
Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder
.
J Am Acad Child Adolesc Psychiatry
.
2010 Jun 1
;
49
(
6
):
573
82
.
44.
Findling
RL
,
Turnbow
J
,
Burnside
J
,
Melmed
R
,
Civil
R
,
Li
Y
.
A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents
.
CNS Spectr
.
2010 Jul
;
15
(
7
):
419
30
.
45.
Newcorn
JH
,
Nagy
P
,
Childress
AC
,
Frick
G
,
Yan
B
,
Pliszka
S
.
Randomized, double-blind, placebo-controlled acute comparator trials of lisdexamfetamine and extended-release methylphenidate in adolescents with attention-deficit/hyperactivity disorder
.
CNS Drugs
.
2017 Nov
;
31
(
11
):
999
1014
.
46.
Pelham
WE
,
Smith
BH
,
Evans
SW
,
Bukstein
O
,
Gnagy
EM
,
Greiner
AR
,
.
The effectiveness of short- and long-acting stimulant medications for adolescents with ADHD in a naturalistic secondary school setting
.
J Atten Disord
.
2017
;
21
(
1
):
40
5
.
47.
Wilens
TE
,
McBurnett
K
,
Bukstein
O
,
McGough
J
,
Greenhill
L
,
Lerner
M
,
.
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder
.
Arch Pediatr Adolesc Med
.
2006 Jan
;
160
(
1
):
82
90
.
48.
Findling
RL
,
Childress
AC
,
Cutler
AJ
,
Gasior
M
,
Hamdani
M
,
Ferreira-Cornwell
MC
,
.
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder
.
J Am Acad Child Adolesc Psychiatry
.
2011 Apr
;
50
(
4
):
395
405
.
49.
Spencer
TJ
,
Wilens
TE
,
Biederman
J
,
Weisler
RH
,
Read
SC
,
Pratt
R
.
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study
.
Clin Therapeut
.
2006 Feb
;
28
(
2
):
266
79
.
50.
Bostic
JQ
,
Biederman
J
,
Spencer
TJ
,
Wilens
TE
,
Prince
JB
,
Monuteaux
MC
,
.
Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial
.
J Child Adolesc Psychopharmacol
.
2000 Fall
;
10
(
3
):
205
16
.
51.
Bangs
ME
,
Bangs
ME
,
Emslie
GJ
,
Spencer
TJ
,
Ramsey
JL
,
Carlson
C
,
.
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression
.
J Child Adolesc Psychopharmacol
.
2007 Aug
;
17
(
4
):
407
20
.
52.
Biederman
J
,
Melmed
RD
,
Patel
A
,
McBurnett
K
,
Konow
J
,
Lyne
A
,
.
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
.
Pediatrics
.
2008 Jan
;
121
(
1
):
e73
84
.
53.
Sallee
FR
,
McGough
J
,
Wigal
T
,
Donahue
J
,
Lyne
A
,
Biederman
J
,
.
Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial
.
J Am Acad Child Adolesc Psychiatry
.
2009 Feb
;
48
(
2
):
155
65
.
54.
Wilens
TE
,
Robertson
B
,
Sikirica
V
,
Harper
L
,
Young
JL
,
Bloomfield
R
,
.
A randomized, placebo-controlled trial of guanfacine extended release in adolescents with attention-deficit/hyperactivity disorder
.
J Am Acad Child Adolesc Psychiatry
.
2015 Nov
;
54
(
11
):
916
e2
.
55.
Childress
A
.
The safety of extended-release drug formulations for the treatment of ADHD
.
Expert Opin Drug Saf
.
2017 May
;
16
(
5
):
603
15
.
56.
Liang
EF
,
Lim
SZ
,
Tam
WW
,
Ho
CS
,
Zhang
MW
,
McIntyre
RS
,
.
The effect of methylphenidate and atomoxetine on heart rate and systolic blood pressure in young people and adults with attention-deficit hyperactivity disorder (ADHD): systematic review, meta-analysis, and meta-regression
.
Int J Environ Res Publ Health
.
2018 Aug 20
;
15
(
8
):
1789
.
57.
Cooper
WO
,
Habel
LA
,
Sox
CM
,
Chan
KA
,
Arbogast
PG
,
Cheetham
TC
,
.
ADHD drugs and serious cardiovascular events in children and young adults
.
N Engl J Med
.
2011 Nov 17
;
365
(
20
):
1896
904
.
58.
Habel
LA
,
Cooper
WO
,
Sox
CM
,
Chan
KA
,
Fireman
BH
,
Arbogast
PG
,
.
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults
.
JAMA
.
2011 Dec 28
;
306
(
24
):
2673
83
.
59.
Crunelle
CL
,
van den Brink
W
,
Moggi
F
,
Konstenius
M
,
Franck
J
,
Levin
FR
,
.
International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder
.
Eur Addiction Res
.
2018
;
24
(
1
):
43
51
.
60.
Jones
J
,
Hunter
D
.
Consensus methods for medical and health services research
.
BMJ
.
1995 Aug 5
;
311
(
7001
):
376
80
.
61.
Hendriks
V
,
Özgen
H
,
Spijkerman
R
.
Screening, diagnosis and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder: a systematic review. background document to inform the development of a consensus statement
.
The hague: parnassia addiction research centre (PARC), brijder addiction treatment
.
Parnassia Group
. Forthcoming
2020
.
62.
Agabio
R
,
Sinclair
JM
,
Addolorato
G
,
Aubin
HJ
,
Beraha
,
EM
,
Caputo
F
,
.
Baclofen for the treatment of alcohol use disorder: the Cagliari statement
.
Lancet Psychiatry
.
2018 Dec
;
5
(
12
):
957
60
.
63.
van de Glind
G
,
Brynte
C
,
Skutle
A
,
Kaye
S
,
Konstenius
M
,
Levin
F
,
.
The international collaboration on ADHD and substance abuse (ICASA): mission, results, and future activities
.
Eur Addict Res
.
Forthcoming 2020
.
You do not currently have access to this content.